Deml L - Search Results

1

The past, present and future of HIV-vaccine development: a critical view.

Bojak A, Deml L, Wagner R. Bojak A, et al. Among authors: deml l. Drug Discov Today. 2002 Jan 1;7(1):36-46. doi: 10.1016/s1359-6446(01)02081-5. Drug Discov Today. 2002. PMID: 11790602 Review.

2

Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines.

Bojak A, Wild J, Deml L, Wagner R. Bojak A, et al. Among authors: deml l. Intervirology. 2002;45(4-6):275-86. doi: 10.1159/000067919. Intervirology. 2002. PMID: 12566710

3

HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.

Kofman A, Graf M, Bojak A, Deml L, Bieler K, Kharazova A, Wolf H, Wagner R. Kofman A, et al. Among authors: deml l. Tsitologiia. 2003;45(1):86-93. Tsitologiia. 2003. PMID: 12683241

4

Co-influence of transgene expression in mammalian cells. Mutual influence of transgenes on their expression in mammalian cells.

Kofman A, Graf M, Deml L, Kharazova A, Wolf H, Wagner R. Kofman A, et al. Among authors: deml l. Tsitologiia. 2003;45(4):387-91. Tsitologiia. 2003. PMID: 14520870

5

Virus-like particles: a novel tool for the induction and monitoring of both T-helper and cytotoxic T-lymphocyte activity.

Deml L, Wild J, Wagner R. Deml L, et al. Methods Mol Med. 2004;94:133-57. doi: 10.1385/1-59259-679-7:133. Methods Mol Med. 2004. PMID: 14959827

6

Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA.

Graf M, Deml L, Wagner R. Graf M, et al. Among authors: deml l. Methods Mol Med. 2004;94:197-210. doi: 10.1385/1-59259-679-7:197. Methods Mol Med. 2004. PMID: 14959831

7

Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.

Wild J, Bojak A, Deml L, Wagner R. Wild J, et al. Among authors: deml l. Vaccine. 2004 Apr 16;22(13-14):1732-43. doi: 10.1016/j.vaccine.2004.01.035. Vaccine. 2004. PMID: 15068857

8

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses.

Deml L, Speth C, Dierich MP, Wolf H, Wagner R. Deml L, et al. Mol Immunol. 2005 Feb;42(2):259-77. doi: 10.1016/j.molimm.2004.06.028. Mol Immunol. 2005. PMID: 15488613 Review.

9

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K. Kuate S, et al. Among authors: deml l. Virology. 2006 Jul 20;351(1):133-44. doi: 10.1016/j.virol.2006.03.009. Epub 2006 Apr 17. Virology. 2006. PMID: 16616946 Free article.

10

Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes.

Speth C, Bredl S, Hagleitner M, Wild J, Dierich M, Wolf H, Schroeder J, Wagner R, Deml L. Speth C, et al. Among authors: deml l. Virology. 2008 Dec 5;382(1):46-58. doi: 10.1016/j.virol.2008.08.043. Epub 2008 Oct 21. Virology. 2008. PMID: 18945465 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters